A 52-week prophylactic randomised control trial of omega-3 polyunsaturated fatty acids in bipolar disorder.
Bipolar Disord
; 23(7): 697-706, 2021 11.
Article
in En
| MEDLINE
| ID: mdl-33340432
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bipolar Disorder
/
Fatty Acids, Omega-3
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Bipolar Disord
Journal subject:
PSIQUIATRIA
Year:
2021
Document type:
Article
Country of publication:
Denmark